Mircette - Side Effects & Drug Interactions

desogestrel/ ethinyl estradiol and ethinyl estradiol

ADVERSE REACTIONS

An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS section):

° Thrombophlebitis and venous

° Cerebral hemorrhage thrombosis with or without embolism

° Cerebral thrombosis

° Arterial thromboembolism

° Hypertension

° Pulmonary embolism

° Gallbladder disease

° Myocardial infarction

° Hepatic adenomas or benign liver tumors

There is evidence of an association between the following conditions and the use of oral contraceptives:

° Mesenteric thrombosis

° Retinal thrombosis

The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:



° Nausea

° Change in weight (increase or decrease)

° Vomiting

° Change in cervical erosion and secretion

° Gastrointestinal symptoms (such as abdominal cramps and bloating)

° Diminution in lactation when given immediately postpartum

° Breakthrough bleeding

° Cholestatic jaundice

° Spotting

° Migraine

° Change in menstrual flow

° Rash (allergic)

° Amenorrhea

° Mental depression

° Temporary infertility after discontinuation of treatment

° Reduced tolerance to carbohydrates

° Vaginal candidiasis

° Edema

° Change in corneal curvature (steepening)

° Melasma which may persist

° Intolerance to contact lenses

° Breast changes: tenderness, enlargement, secretion

The following adverse reactions have been reported in users of oral contraceptives and the association has been neither confirmed nor refuted:

° Pre-menstrual syndrome

° Erythema nodosum

° Cataracts

° Hemorrhagic eruption

° Changes in appetite

° Vaginitis

° Cystitis-like syndrome

° Porphyria

° Headache

° Impaired renal function

° Nervousness

° Hemolytic uremic syndrome

° Dizziness

° Acne

° Hirsutism

° Changes in libido

° Loss of scalp hair

° Colitis

° Erythema multiforme

° Budd-Chiari Syndrome


Find a Therapist

Powered by Psychology Today


PR Newswire